Omicron Booster Dose India
- All
- News
- Videos
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
Everyone Will Get Omicron, Boosters Won't Stop It: Top Medical Expert
Stressing that Covid is "not a frightening disease anymore" as the new strain is milder and is leading to much less hospitalisation, he said that it's a disease we can deal with.
-
3rd Covaxin Dose Holds Promise: Medical Body Ahead Of Booster Dose Drive
Third dose of Covaxin holds promise, Indian Council of Medical Research said on Sunday just a day before government plans to administer 'precaution' doses of Covid vaccines to frontline, healthcare workers and senior citizens with co-morbidities.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
New Registration Not Needed For Covid Vaccine Booster Shot: Centre
There is no need for new registration for those taking the precautionary dose of COVID-19 vaccine and they can directly take an appointment from today or walk-in, the Union Health Ministry said.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Booster Dose To Mitigate Covid Severity, Hospitalisation, Death: Centre
The government also assured the people that there is no need to panic due to rising Covid cases as we are prepared for a surge.
-
Vaccine Booster Dose: For Precaution Dose, No Mix-And-Match Of Vaccines: Government Sources
There will be no mix-and-match of vaccines for the crucial third dose to be given in view of the Omicron variant that is rapidly spreading in the country, senior health ministry sources told NDTV today.
-
422 Omicron Cases In India, Most In Maharashtra, Followed By Delhi
The number of cases of fast-spreading Omicron variant has risen to 422 in India, with Maharashtra reporting the most number of infections. India has announced "precaution doses" for front-line workers and those above 60 from January 10.
-
PM's Speech Highlights: Booster Doses Announced, Vaccines For Children
The Prime Minister said that as people prepare to welcome the new year with hope and celebration, it's also a time to be careful as the highly contagious Omicron variant is rapidly pushing up Covid infections.
-
Amid Omicron Fears, Government To Study Benefit Of Booster Dose: Sources
The government will conduct a medical study - on 3,000 fully vaccinated individuals - to assess the efficacy of a Covid vaccine booster against the Omicron variant, Health Ministry sources said Friday.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
Everyone Will Get Omicron, Boosters Won't Stop It: Top Medical Expert
Stressing that Covid is "not a frightening disease anymore" as the new strain is milder and is leading to much less hospitalisation, he said that it's a disease we can deal with.
-
3rd Covaxin Dose Holds Promise: Medical Body Ahead Of Booster Dose Drive
Third dose of Covaxin holds promise, Indian Council of Medical Research said on Sunday just a day before government plans to administer 'precaution' doses of Covid vaccines to frontline, healthcare workers and senior citizens with co-morbidities.
-
Booster Dose Protects Adults Above 65 Against Omicron Infections: UK Study
A third top-up booster dose of a COVID-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday.
-
New Registration Not Needed For Covid Vaccine Booster Shot: Centre
There is no need for new registration for those taking the precautionary dose of COVID-19 vaccine and they can directly take an appointment from today or walk-in, the Union Health Ministry said.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Booster Dose To Mitigate Covid Severity, Hospitalisation, Death: Centre
The government also assured the people that there is no need to panic due to rising Covid cases as we are prepared for a surge.
-
Vaccine Booster Dose: For Precaution Dose, No Mix-And-Match Of Vaccines: Government Sources
There will be no mix-and-match of vaccines for the crucial third dose to be given in view of the Omicron variant that is rapidly spreading in the country, senior health ministry sources told NDTV today.
-
422 Omicron Cases In India, Most In Maharashtra, Followed By Delhi
The number of cases of fast-spreading Omicron variant has risen to 422 in India, with Maharashtra reporting the most number of infections. India has announced "precaution doses" for front-line workers and those above 60 from January 10.
-
PM's Speech Highlights: Booster Doses Announced, Vaccines For Children
The Prime Minister said that as people prepare to welcome the new year with hope and celebration, it's also a time to be careful as the highly contagious Omicron variant is rapidly pushing up Covid infections.
-
Amid Omicron Fears, Government To Study Benefit Of Booster Dose: Sources
The government will conduct a medical study - on 3,000 fully vaccinated individuals - to assess the efficacy of a Covid vaccine booster against the Omicron variant, Health Ministry sources said Friday.
